Science Corp Raises $230M to Commercialize Vision Restoration Implant
Max Hodak's neurotechnology startup secures major funding round to bring its retinal implant system to market, signaling renewed investor confidence in sensory BCI applications.
3 articles
Max Hodak's neurotechnology startup secures major funding round to bring its retinal implant system to market, signaling renewed investor confidence in sensory BCI applications.
Science Corporation closes a $230 million Series C led by Khosla Ventures and Lightspeed, pushing its valuation past $1 billion as it targets European launch of the PRIMA vision-restoration implant by mid-2026.
The cryptocurrency giant's massive investment in one of the oldest BCI companies signals an unexpected collision between digital currency and neurotechnology sectors.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. Unsubscribe anytime. We respect your privacy.